A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this dose escalation study is to examine the safety and pharmacokinetics (PK)
of AGS-16M8F administered in subjects with advanced renal cell carcinoma.